 The advantage of rilpivirine over etravirine is a better bioavailability and it is easier to formulate than etravirine.Etravirine has required extensive chemical formulation work due to poor solubility and bioavailability.Rilpivirine was undergoing phase III clinical trials in the end of 2009.